Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-31 · accession 0001567619-22-019037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-01 | 2022-10-31 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale | $86.55 | -1,500 | 322.8K | -0.5% | -$129.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | S | D | 1,500 | $86.55 | 322,824 | D | — | — |